Beate Mayer
Overview
Explore the profile of Beate Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hermann S, Althaus K, Mustafi M, Mayer B, Rosenberger P, Haeberle H, et al.
Front Immunol
. 2025 Feb;
16:1464014.
PMID: 40007538
Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient...
2.
de Winter D, Lopriore E, Thorup E, Petersen O, Dziegiel M, Sundberg K, et al.
Lancet Haematol
. 2024 Nov;
11(12):e927-e937.
PMID: 39527958
Background: Advances in haemolytic disease of the fetus and newborn have led to numerous treatment options. We report practice variations in the management and outcomes of haemolytic disease of the...
3.
Tober-Lau P, Kneller A, Lingscheid T, Mayer B, Zoller T, Kurth F
J Travel Med
. 2024 Mar;
31(8).
PMID: 38470296
In a cohort of patients treated with oral artemisinin combination therapy for uncomplicated malaria, the presence of anti-red blood cell (RBC) auto-antibodies does not correlate with the extent of post-treatment...
4.
Bartolmas T, Pruss A, Mayer B
Front Immunol
. 2023 Feb;
14:1114509.
PMID: 36817469
Antibodies to red blood cells (RBCs) may hemolyze erythrocytes Fc-mediated phagocytosis or complement-dependent. Complement activation on RBCs can be detected by C3d-direct antiglobulin test (DAT), which is the only test...
5.
Kurth F, Tober-Lau P, Lingscheid T, Bardtke L, Kim J, Angheben A, et al.
J Travel Med
. 2023 Jan;
30(3).
PMID: 36611010
Background: Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe...
6.
Ringel F, Kiesewetter H, Mayer B, Bartolmas T, Sehouli J, Salama A
Transfusion
. 2022 Nov;
62(12):2648-2652.
PMID: 36325695
Background: We describe here the first patient with recurrent hemolysis related to disinfectant containing silver nanoparticles (AgNps). Methods: A 58-year-old chemist repeatedly experienced DAT-negative (Coombs-negative) hemolysis during the last 5 ...
7.
Balola A, Mayer B, Bartolmas T, Salama A
Vox Sang
. 2021 May;
116(10):1106-1116.
PMID: 33942922
Background And Objectives: The significance of antibodies to red blood cells (RBCs) is variable and cannot be predicted solely by serological testing. A flow cytometry-based erythrophagocytosis assay was established using...
8.
Thornton N, Karamatic Crew V, Tilley L, Green C, Tay C, Griffiths R, et al.
Nat Commun
. 2020 Jul;
11(1):3569.
PMID: 32678083
The clinically important MAM blood group antigen is present on haematopoietic cells of all humans except rare MAM-negative individuals. Its molecular basis is unknown. By whole-exome sequencing we identify EMP3,...
9.
Roehmel J, Specht P, Staab D, Schwarz C, Salama A, Mayer B
Transfusion
. 2019 Nov;
59(12):3746-3754.
PMID: 31724753
Background: Drug-induced immune hemolytic anemia (DIIHA) is a rare but severe side effect caused by numerous drugs. Case reports and case series suggest that piperacillin-related DIIHA may be more common...
10.
Balola A, Mayer B, Bartolmas T, Salama A
Cell Physiol Biochem
. 2019 Aug;
53(3):453-464.
PMID: 31448885
Background/aims: Eryptosis, the suicidal death of red blood cells (RBCs), is characterized by phosphatidylserine (PS) exposure at the cell surface. It can be catalysed by a variety of abnormal conditions...